186574790	186574790	CD	B-NP	O
|	|	NN	I-NP	O
MOMC	MOMC	NN	I-NP	O
|	|	NN	I-NP	O
02617362	02617362	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5181114	5181114	CD	B-NP	O
|	|	CC	I-NP	O
11/3/2006	11/3/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RESPIRATORY	RESPIRATORY	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/4/2006	2/4/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/30/2006	8/30/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MOLLEKER	MOLLEKER	NN	B-NP	O
,	,	,	O	O
LOWELL	LOWELL	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
CHIEF	CHIEF	NNP	I-NP	O
COMPLAINT/REASON	COMPLAINT/REASON	NNP	I-NP	O
FOR	FOR	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Confusion	Confusion	NN	B-NP	O
,	,	,	O	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypercarbic	hypercarbic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54-year-old	54-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
asthma/COPD	asthma/COPD	NN	B-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
BiPAP	BiPAP	NN	B-NP	B-protein
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
somnolence	somnolence	NN	B-NP	O
.	.	.	O	O

Apparently	Apparently	RB	B-ADVP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
progressively	progressively	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
confused	confused	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
lethargic	lethargic	JJ	I-ADJP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
and	and	CC	O	O
walks	walk	VBZ	B-VP	O
intermittently	intermittently	RB	B-ADVP	O
with	with	IN	B-PP	O
walker	walker	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
,	,	,	O	O
at	at	IN	B-PP	O
most	most	JJS	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
bedbound	bedbound	VBN	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
obesity	obesity	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
injured	injure	VBN	I-NP	O
knee	knee	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
week	week	NN	I-NP	O
apparently	apparently	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
machine	machine	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
like	like	IN	B-PP	O
she	she	PRP	B-NP	O
``	``	``	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
getting	get	VBG	I-VP	O
any	any	DT	B-NP	O
air	air	NN	I-NP	O
''	''	''	O	O
.	.	.	O	O

Apparently	Apparently	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
had	have	VBD	B-VP	O
called	call	VBN	I-VP	O
the	the	DT	B-NP	O
company	company	NN	I-NP	O
that	that	WDT	B-NP	O
supplies	supply	VBZ	B-VP	O
the	the	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
had	have	VBD	B-VP	O
come	come	VBN	I-VP	O
in	in	IN	B-ADVP	O
and	and	CC	O	O
said	say	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
should	should	MD	B-VP	O
figure	figure	VB	I-VP	O
out	out	RP	B-PRT	O
how	how	WRB	B-ADVP	O
to	to	TO	B-VP	O
fix	fix	VB	I-VP	O
it	it	PRP	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
him	him	PRP	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
getting	get	VBG	I-VP	O
oxygen	oxygen	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
any	any	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
cough	cough	NN	B-NP	O
or	or	CC	O	O
sputum	sputum	NN	B-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fever	fever	NN	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
not	not	RB	O	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
swelling/deformity	swelling/deformity	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
increased	increase	VBN	I-NP	O
erythema	erythema	NN	I-NP	O
or	or	CC	I-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
had	have	VBN	I-VP	O
any	any	DT	B-NP	O
recent	recent	JJ	I-NP	O
long	long	JJ	I-NP	O
trips	trip	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
somewhat	somewhat	RB	I-VP	O
bed	bed	VBN	I-VP	O
bound	bind	VBN	I-VP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
knee	knee	NN	I-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
increasing	increase	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
somnolence	somnolence	NN	B-NP	O
and	and	CC	O	O
apparently	apparently	RB	B-NP	O
hallucinations	hallucination	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
unarousable	unarousable	JJ	B-ADJP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
found	find	VBD	B-VP	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
sats	sat	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
in	in	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
lethargic	lethargic	JJ	B-ADJP	O
and	and	CC	O	O
moaning	moan	VBG	B-VP	O
incoherently	incoherently	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
vitals	vital	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
were	be	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
97.6	97.6	CD	B-NP	O
Fahrenheit	Fahrenheit	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
178/46	178/46	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
106	106	CD	B-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
,	,	,	O	O
breathing	breathe	VBG	B-VP	O
36	36	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
minute	minute	NN	I-NP	O
and	and	CC	O	O
satting	satte	VBG	B-VP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
nonrebreather	nonrebreather	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
220	220	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
trachea	trachea	NN	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Fentanyl	Fentanyl	NN	B-NP	O
,	,	,	O	O
Valium	Valium	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Atrovent	Atrovent	NNP	B-NP	O
nebs	neb	NNS	I-NP	O
and	and	CC	O	O
Solu-Medrol	Solu-Medrol	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
,	,	,	O	O
asthma/COPD	asthma/COPD	NN	B-NP	O
without	without	IN	B-PP	O
known	known	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
testing	testing	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
weighing	weigh	VBG	B-VP	O
approximately	approximately	RB	B-NP	O
460	460	CD	I-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-	-	HYPH	B-VP	O
she	she	PRP	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
tolerate	tolerate	VB	I-VP	O
CPAP	CPAP	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
distant	distant	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
in	in	IN	B-PP	O
4/3	4/3	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
furosemide	furosemide	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
inhalers	inhaler	NNS	I-NP	O
,	,	,	O	O
Motrin	Motrin	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
metoprolol	metoprolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
3	3	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
3L	3L	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
home	home	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
former	former	JJ	I-NP	O
bus	bus	NN	I-NP	O
driver	driver	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
,	,	,	O	O
Troisi	Troisi	NNP	B-NP	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
or	or	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	O	O
illicit	illicit	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Noncontributory	Noncontributory	JJ	B-ADJP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
temperature	temperature	NN	I-NP	O
was	be	VBD	B-VP	O
97.6	97.6	CD	B-NP	O
degree	degree	NN	I-NP	O
Fahrenheit	Fahrenheit	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
106	106	CD	B-NP	O
and	and	CC	O	O
regular	regular	JJ	B-ADJP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
130/50	130/50	CD	B-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
opened	open	VBD	B-VP	O
her	her	PRP$	B-NP	O
eyes	eye	NNS	I-NP	O
to	to	TO	B-PP	O
sternal	sternal	JJ	B-NP	O
rub	rub	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
to	to	TO	I-PP	O
voice	voice	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pupils	pupil	NNS	I-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
and	and	CC	O	O
2	2	CD	B-NP	O
mm	mm	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
Sounds	Sound	NNS	B-NP	O
were	be	VBD	B-VP	O
coarse	coarse	NN	B-NP	O
anterior	anterior	RB	B-ADVP	O
and	and	CC	I-ADVP	O
laterally	laterally	RB	I-ADVP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
had	have	VBD	B-VP	O
distant	distant	JJ	B-NP	O
,	,	,	I-NP	O
distant	distant	JJ	I-NP	O
heart	heart	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
jugular	jugular	JJ	I-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
assessed	assess	VBN	I-VP	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
size	size	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
distal	distal	JJ	I-NP	O
,	,	,	I-NP	O
radial	radial	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
dorsalis	dorsalis	NN	B-NP	O
pedis	pedis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
all	all	DT	B-NP	O
palpable	palpable	JJ	I-NP	B-DNA
1	1	CD	I-NP	I-DNA
+	+	SYM	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

Bowel	Bowel	NN	B-NP	O
sounds	sound	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
and	and	CC	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
midline	midline	NN	I-NP	O
scar	scar	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
were	be	VBD	B-VP	O
cool	cool	JJ	B-ADJP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
venostasis	venostasis	NN	I-NP	O
changes	change	NNS	I-NP	O
perhaps	perhaps	RB	B-ADVP	O
lymphedema	lymphedema	VBP	B-VP	O
changes	change	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Left	Leave	VBN	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
was	be	VBD	B-VP	O
23	23	CD	B-NP	O
inches	inch	NNS	I-NP	O
and	and	CC	O	O
right	right	RB	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
was	be	VBD	B-VP	O
18	18	CD	B-NP	O
inches	inch	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
calf	calf	NN	I-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
stated	state	VBN	B-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
opens	open	VBZ	B-VP	O
her	her	PRP$	B-NP	O
eyes	eye	NNS	I-NP	O
to	to	TO	B-PP	O
sternal	sternal	JJ	B-NP	O
rub	rub	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
144	144	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.3	4.3	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
95	95	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
0.7	0.7	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
236	236	CD	B-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
of	of	IN	B-PP	O
8.9	8.9	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
,	,	,	O	O
phosphorous	phosphorous	JJ	B-ADJP	O
of	of	IN	B-PP	O
4.7	4.7	CD	B-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	O
of	of	IN	B-PP	O
23	23	CD	B-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
of	of	IN	B-PP	O
2.1	2.1	CD	B-NP	O
,	,	,	O	O
alkaline	alkaline	JJ	B-NP	B-protein
phosphatase	phosphatase	NN	I-NP	I-protein
of	of	IN	B-PP	O
78	78	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
albumin	albumin	NN	B-NP	O
of	of	IN	B-PP	O
3.9	3.9	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
protein	protein	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	B-protein
leukocyte	leukocyte	NN	I-NP	I-protein
esterase	esterase	NN	I-NP	I-protein
,	,	,	O	O
negative	negative	JJ	B-NP	O
nitrites	nitrite	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
bacteria	bacteria	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
trichomonas	trichomona	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
D-dimer	D-dimer	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1330	1330	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
13	13	CD	B-NP	O
,	,	,	O	O
000	000	CD	B-NP	O
with	with	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
neutrophils	neutrophil	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
42.4	42.4	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
platelet	platelet	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
164	164	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
MCV	MCV	NN	I-NP	O
was	be	VBD	B-VP	O
93	93	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
anti-PF4	anti-PF4	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
,	,	,	O	O
also	also	RB	B-VP	O
known	know	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
HIT	HIT	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
PTT	PTT	NN	I-NP	O
was	be	VBD	B-VP	O
26.3	26.3	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	O
tox	tox	NN	I-NP	O
screens	screen	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
reveal	reveal	VB	I-VP	O
any	any	DT	B-NP	O
toxins	toxin	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
radiograph	radiograph	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
quality	quality	NN	I-NP	O
film	film	NN	I-NP	O
given	give	VBN	B-VP	O
the	the	DT	B-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
film	film	NN	I-NP	O
was	be	VBD	B-VP	O
rotated	rotate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
ET	ET	NN	I-NP	B-DNA
tube	tube	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
3.5	3.5	CD	B-NP	O
cm	cm	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
corner	corner	NN	I-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-ADVP	O
,	,	,	O	O
extraordinarily	extraordinarily	RB	B-ADVP	O
limited	limited	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
gross	gross	JJ	I-NP	O
consolidation	consolidation	NN	I-NP	O
or	or	CC	I-NP	O
effusions	effusion	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
or	or	CC	O	O
V/Q	V/Q	NN	B-NP	O
scan	scan	NN	I-NP	O
were	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
abdominal	abdominal	JJ	I-NP	O
girth	girth	NN	I-NP	O
prevented	prevent	VBD	B-VP	O
either	either	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
from	from	IN	B-PP	O
being	be	VBG	B-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

Lower	Low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
noninvasive	noninvasive	JJ	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
clot	clot	NN	I-NP	O
although	although	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
on	on	IN	B-PP	O
10/28/06	10/28/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
grew	grow	VBD	B-VP	O
mixed	mixed	JJ	B-NP	O
flora	flora	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54-year-old	54-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
and	and	CC	I-NP	O
obesity	obesity	NN	I-NP	O
with	with	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
respiratory	respiratory	JJ	B-NP	O
changes	change	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
hypoxemia	hypoxemia	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEM	SYSTEM	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Her	Her	PRP$	B-NP	O
trachea	trachea	NN	I-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
within	within	IN	B-PP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
coming	come	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
Intensive	Intensive	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
first	first	JJ	B-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
quite	quite	RB	B-ADVP	O
well	well	RB	I-ADVP	O
on	on	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
at	at	IN	B-PP	O
25	25	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
5	5	CD	I-NP	I-DNA
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
became	become	VBD	B-VP	O
a	a	DT	B-NP	O
bit	bit	NN	I-NP	O
more	more	RBR	B-ADJP	O
somnolent	somnolent	JJ	I-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
intubate	intubate	VB	I-VP	O
her	her	PRP$	B-NP	O
trachea	trachea	NN	I-NP	O
once	once	RB	B-ADVP	O
again	again	RB	I-ADVP	O
within	within	IN	B-PP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ABG	ABG	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
FiO2	FiO2	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
7.19	7.19	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
CO2	CO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
119	119	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
of	of	IN	B-PP	O
106	106	CD	B-NP	O
with	with	IN	B-PP	O
saturation	saturation	NN	B-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
preparing	prepare	VBG	I-VP	O
to	to	TO	I-VP	O
intubate	intubate	VB	I-VP	O
the	the	DT	B-NP	O
trachea	trachea	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
alert	alert	JJ	I-ADJP	O
and	and	CC	O	O
requested	request	VBN	B-VP	O
to	to	TO	I-VP	O
speak	speak	VB	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
son	son	NN	I-NP	O
beforehand	beforehand	NN	I-NP	O
and	and	CC	O	O
saying	say	VBG	B-VP	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
want	want	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
tube	tube	NN	I-NP	O
down	down	RP	B-PRT	O
her	her	PRP$	B-NP	O
throat	throat	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
son	son	NN	I-NP	O
came	come	VBD	B-VP	O
in	in	IN	B-PP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
making	make	VBG	I-VP	O
more	more	JJR	B-NP	O
sense	sense	NN	I-NP	O
and	and	CC	O	O
asking	ask	VBG	B-VP	O
us	us	PRP	B-NP	O
not	not	RB	O	O
to	to	TO	B-VP	O
intubate	intubate	VB	I-VP	O
her	her	PRP$	B-NP	O
trachea	trachea	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
observe	observe	VB	I-VP	O
her	her	PRP	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
BiPAP	BiPAP	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
her	her	PRP$	B-NP	O
carbon	carbon	NN	I-NP	O
dioxide	dioxide	NN	I-NP	O
had	have	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
103	103	CD	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
by	by	IN	B-PP	O
3	3	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
that	that	IN	B-NP	O
it	it	PRP	B-NP	O
actually	actually	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
arterial	arterial	JJ	I-NP	O
blood	blood	NN	I-NP	O
gas	gas	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
pH	pH	NN	B-NP	O
of	of	IN	B-PP	O
7.32	7.32	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PCO2	PCO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PO2	PO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
71	71	CD	B-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
of	of	IN	B-PP	O
actual	actual	JJ	B-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
intermittently	intermittently	RB	B-ADVP	O
at	at	IN	B-PP	O
various	various	JJ	B-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
final	final	JJ	I-NP	O
settings	setting	NNS	I-NP	O
were	be	VBD	B-VP	O
pressure	pressure	NN	B-NP	O
support	support	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
PEEP	PEEP	NN	I-NP	B-protein
of	of	IN	B-PP	O
5	5	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CO2	CO2	NN	I-NP	B-protein
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
60s	60s	CD	I-NP	O
to	to	TO	B-PP	O
99	99	CD	B-NP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
clear	clear	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
her	her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
CO2s	CO2	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
thought	thought	NN	I-NP	O
was	be	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
CO2	CO2	NN	I-NP	O
was	be	VBD	B-VP	O
probably	probably	RB	B-ADVP	O
somewhere	somewhere	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
70s	70	NNS	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
pH	pH	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
with	with	IN	B-PP	O
PCO2	PCO2	NN	B-NP	B-protein
around	around	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
carbon	carbon	NN	I-NP	O
dioxide	dioxide	NN	I-NP	O
retainer	retainer	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
bicarbonates	bicarbonate	NNS	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
here	here	RB	B-ADVP	O
previously	previously	RB	B-ADVP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	NN	I-NP	O
to	to	TO	B-PP	O
high	high	JJ	B-NP	O
30s	30	NNS	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
40s	40	NNS	I-NP	O
just	just	RB	B-ADVP	O
as	as	IN	B-SBAR	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
just	just	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
hypercarbic	hypercarbic	JJ	I-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
episodes	episode	NNS	B-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
become	become	VBP	B-VP	O
slightly	slightly	RB	B-ADJP	O
less	less	RBR	I-ADJP	O
responsive	responsive	JJ	I-ADJP	O
always	always	RB	B-ADVP	O
will	will	MD	B-VP	O
awake	awake	VB	I-VP	O
with	with	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
physical	physical	JJ	I-NP	O
stimuli	stimulus	NNS	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
give	give	VB	I-VP	O
appropriate	appropriate	JJ	B-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
corticosteroids	corticosteroid	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
given	give	VBN	I-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
large	large	JJ	B-NP	O
a	a	DT	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
component	component	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
Levofloxacin	Levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
and	and	CC	O	O
Atrovent	Atrovent	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
inhaled	inhale	VBN	I-NP	O
corticosteroid	corticosteroid	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
especially	especially	RB	B-ADJP	O
given	give	VBN	I-ADJP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

Unfortunately	Unfortunately	RB	B-ADVP	O
,	,	,	O	O
diagnostic	diagnostic	JJ	B-NP	O
imaging	imaging	NN	I-NP	O
was	be	VBD	B-VP	O
inadequate	inadequate	JJ	B-ADJP	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
girth	girth	NN	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
discussion	discussion	NN	B-NP	O
of	of	IN	B-PP	O
putting	put	VBG	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
felt	feel	VBD	B-VP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
to	to	TO	I-NP	O
moderate	moderate	JJ	I-NP	O
probability	probability	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolus	embolus	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
risks	risk	NNS	I-NP	O
of	of	IN	B-PP	O
long-term	long-term	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
outweigh	outweigh	VBP	B-VP	O
the	the	DT	B-NP	O
benefits	benefit	NNS	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
probably	probably	RB	B-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
or	or	CC	O	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
agreed	agree	VBD	B-VP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
decision	decision	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
readdressed	readdresse	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
centered	center	VBN	I-VP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolus	embolus	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
pelvic	pelvic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
and	and	CC	O	O
likely	likely	RB	B-VP	O
did	do	VBD	I-VP	O
not	not	RB	I-VP	O
reflex	reflex	VB	I-VP	O
any	any	DT	B-NP	O
increased	increase	VBN	I-NP	O
likelihood	likelihood	NN	I-NP	O
of	of	IN	B-PP	O
thrombosis	thrombosis	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
enoxaparin	enoxaparin	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
for	for	IN	B-PP	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
bedbound	bedbound	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
enteric-coated	enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
discharged	discharge	VBD	I-VP	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
and	and	CC	I-NP	O
Aspart	Aspart	NN	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
resumed	resume	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
sulfonylurea	sulfonylurea	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
good	good	JJ	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
metformin	metformin	NN	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
and	and	CC	I-NP	O
likely	likely	JJ	I-NP	O
poor	poor	JJ	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Obstructive	Obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
with	with	IN	B-PP	O
known	know	VBN	B-NP	O
elevated	elevated	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
90	90	CD	I-NP	O
+	+	SYM	I-NP	O
right	right	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
and	and	CC	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
at	at	IN	B-PP	O
Mertaymonpeters	Mertaymonpeters	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
counseled	counsel	VBN	I-VP	O
and	and	CC	O	O
encouraged	encourage	VBN	B-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
her	her	PRP$	B-NP	O
BiPAP	BiPAP	NN	I-NP	B-protein
or	or	CC	I-NP	O
CPAP	CPAP	NN	I-NP	B-protein
machine	machine	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
time	time	NN	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
likely	likely	JJ	I-NP	O
severe	severe	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
and	and	CC	O	O
known	know	VBN	B-VP	O
vascular	vascular	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

MEDICATION	MEDICATION	NNP	B-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Enoxaparin	Enoxaparin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	O
and	and	CC	I-NP	O
Atrovent	Atrovent	NN	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
every	every	DT	B-NP	O
4	4	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheezing	wheezing	NN	I-NP	O
or	or	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
inhalers	inhaler	NNS	B-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
can	can	MD	B-VP	O
tolerate	tolerate	VB	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
educated	educate	VBN	I-VP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Flovent	Flovent	NNP	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
11	11	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
trichomonas	trichomona	NNS	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Glyburide	Glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
doctor	doctor	NN	I-NP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

BiPAP	BiPAP	NN	B-NP	O
20	20	CD	I-NP	O
for	for	IN	B-PP	O
pressure	pressure	NN	B-NP	O
support	support	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
of	of	IN	B-PP	O
PEEP	PEEP	NN	B-NP	B-protein
every	every	DT	B-NP	O
night	night	NN	I-NP	O
all	all	DT	B-NP	O
,	,	,	O	O
night	night	NN	B-NP	O
and	and	CC	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
required	require	VBN	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
BiPAP	BiPAP	NN	B-NP	B-protein
continuously	continuously	RB	B-ADVP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
48	48	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
except	except	IN	B-SBAR	O
to	to	TO	B-VP	O
speak	speak	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	B-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-2420264	4-2420264	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MONSERRATE	MONSERRATE	NNP	B-NP	O
,	,	,	O	O
KIRBY	KIRBY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SIGNORILE	SIGNORILE	NNP	B-NP	O
,	,	,	O	O
BROCK	BROCK	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6980535	6980535	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
11/8/06	11/8/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
11/8/06	11/8/06	CD	B-NP	O

